[HTML][HTML] EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII)
A Midha, S Dearden, R McCormack - American journal of cancer …, 2015 - ncbi.nlm.nih.gov
Mutations in the epidermal growth factor receptor (EGFR) gene are commonly observed in
non-small-cell lung cancer (NSCLC), particularly in tumors of adenocarcinoma (ADC) …
non-small-cell lung cancer (NSCLC), particularly in tumors of adenocarcinoma (ADC) …
[HTML][HTML] Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed …
The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of metastatic non-small-cell …
Practice Guidelines for the diagnosis, treatment and follow-up of metastatic non-small-cell …
Lung cancer in Malaysia
P Rajadurai, SH How, CK Liam… - Journal of Thoracic …, 2020 - jto.org
Malaysia is a Southeast Asian country occupying parts of the Malay Peninsula and the
island of Borneo. The population of Malaysia (just over 30 million) is multi-ethnic; …
island of Borneo. The population of Malaysia (just over 30 million) is multi-ethnic; …
Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients
LY Wang, JJ Cui, AX Guo, JY Yin - OncoTargets and therapy, 2018 - Taylor & Francis
Compared with various malignant tumors, lung cancer has high incidence and the highest
mortality worldwide. Non-small-cell lung cancer (NSCLC), the most common kind of lung …
mortality worldwide. Non-small-cell lung cancer (NSCLC), the most common kind of lung …
EGFR mutation exists in squamous cell lung carcinoma
Whether EGFR mutation occurs in lung squamous cell carcinoma (SCC) remains a
controversial issue. Although numerous trials have shown positive response to tyrosine …
controversial issue. Although numerous trials have shown positive response to tyrosine …
Prevalence and clinical profile of EGFR mutation in non-small-cell lung carcinoma patients in Southwest China
J Zhou, XB Song, Y Zhou, XJ Lu… - Asian Pacific Journal of …, 2016 - journal.waocp.org
Aims: To investigate the distribution of epidermal growth factor receptor (EGFR) mutations,
and explore any relationships with clinical characteristics in non-small-cell lung carcinoma …
and explore any relationships with clinical characteristics in non-small-cell lung carcinoma …
Analysis of CEA expression and EGFR mutation status in non-small cell lung cancers
ZM Yang, XP Ding, L Pen, L Mei… - Asian Pacific Journal of …, 2014 - koreascience.kr
Background: The serum carcinoembryonic antigen (CEA) level can reflect tumor growth,
recurrence and metastasis. It has been reported that epidermal growth factor receptor …
recurrence and metastasis. It has been reported that epidermal growth factor receptor …
Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia
SH How, CK Liam, MA Zainal Abidin… - Cancer management …, 2022 - Taylor & Francis
Background Although first-and second-generation EGFR TKIs are considered first-line
treatment in EGFRm+ NSCLC, most patients develop resistance and progress, commonly …
treatment in EGFRm+ NSCLC, most patients develop resistance and progress, commonly …
Low‑dose anlotinib combined with EGFR‑TKI can be used as an alternative for EGFR‑TKI‑resistant non‑small cell lung cancer in elderly patients
Y Chen, N Jiang, X Liang, N Chen… - Oncology …, 2023 - spandidos-publications.com
The current treatment options for epidermal growth factor receptor (EGFR) mutation‑positive
lung cancer in the elderly with tyrosine kinase inhibitor (TKI) resistance are limited. Although …
lung cancer in the elderly with tyrosine kinase inhibitor (TKI) resistance are limited. Although …
Therapeutic effects and adverse drug reactions are affected by icotinib exposure and CYP2C19 and EGFR genotypes in Chinese non-small cell lung cancer patients
J Chen, X Zheng, DY Liu, Q Zhao, YW Wu… - Asian Pacific Journal …, 2014 - koreascience.kr
Background: The aim of this study was to evaluate how CYP2C19 affects icotinib and
metabolite'exposure, and to determine whether the exposure and EGFR genotype …
metabolite'exposure, and to determine whether the exposure and EGFR genotype …